BiotechTube
Home/Anviron/Michio Kurosu, PhD
MK

Michio Kurosu, PhD

Principal Investigator & Board of Advisors

Anviron

Therapeutic Areas

Oncology

Anviron Pipeline

DrugIndicationPhase
ANV221Pancreatic Ductal AdenocarcinomaPreclinical
ANV322Solid Tumors (anti-migratory/metastatic focus)Preclinical

Leadership Team at Anviron

BB
Brian Boynton, MD
Chief Medical Officer
JY
Jing Yang, PhD
Board of Advisors
View full Anviron profile